LIU Xinhua, DENG Jianzhong, LYU Gaopeng. Clinical effect of endovascular stent implantation in treatingcarotid artery stenosis in patients with ischemic cerebrovascular disease[J]. Journal of Clinical Medicine in Practice, 2024, 28(13): 87-91, 97. DOI: 10.7619/jcmp.20233818
Citation: LIU Xinhua, DENG Jianzhong, LYU Gaopeng. Clinical effect of endovascular stent implantation in treatingcarotid artery stenosis in patients with ischemic cerebrovascular disease[J]. Journal of Clinical Medicine in Practice, 2024, 28(13): 87-91, 97. DOI: 10.7619/jcmp.20233818

Clinical effect of endovascular stent implantation in treatingcarotid artery stenosis in patients with ischemic cerebrovascular disease

More Information
  • Received Date: November 27, 2023
  • Revised Date: May 02, 2024
  • Available Online: July 19, 2024
  • Objective 

    To observe the clinical effect of endovascular stent implantation in the treatment of patients with ischemic cerebrovascular disease (ICVD) and carotid artery stenosis.

    Methods 

    A total of 83 patients with ICVD treatment were selected and divided into observation group with 43 cases and control group with 40 cases, and the hemodynamic indicators and degree of internal carotid artery stenosis, neural markers and vascular endothelial function, degree of neurological deficits, clinical efficacy, and adverse reactions were compared between the two groups.

    Results 

    Peak systolic velocity (PSV), end-diastolic velocity (EDV), and degree of vascular stenosis in both groups showed a downward trend after treatment, and the declines in PSV, EDV and vascular stenosis in the control group were all significantly smaller than those in the observation group (P < 0.05). After treatment, the positive pentraxin-3 (PTX-3) and neuron-specific enolase (NSE) levels in both groups decreased significantly, while functional movement disorder (FMD) and vascular endothelial growth factor (VEGF) levels increased significantly, and the PTX-3 and NSE levels in the observation group were significantly lower than those in the control group, while the VEGF and FMD levels were significantly higher (P < 0.05). After treatment, scores of the National Institutes of Health Stroke Scale (NIHSS) and the Modified Edinburgh-Scandinavian Stroke Scale (MESSS) in both groups decreased, and the decline in NIHSS score and MESSS in the control group was smaller than that in the observation group. Clinical total effective rate was 80.00% in the control group, which was significantly lower than 97.67% in the observation group (P < 0.05). The incidence of adverse reactions in the observation group was 2.33%, which was significantly lower than 22.50% in the control group (P < 0.05).

    Conclusion 

    Endovascular stent implantation can effectively improve the clinical efficacy of ICVD patients, relieve the degree of vascular stenosis, improve cognitive function, and has higher safety.

  • [1]
    VIRANI S S, ALONSO A, APARICIO H J, et al. Heart disease and stroke statistics-2021 update: a report from the American heart association[J]. Circulation, 2021, 143(8): e254-e743.
    [2]
    MA Q F, LI R, WANG L J, et al. Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: an analysis for the Global Burden of Disease Study 2019[J]. Lancet Public Health, 2021, 6(12): e897-e906. doi: 10.1016/S2468-2667(21)00228-0
    [3]
    XIE Q, WU Y P, PEI J H, et al. Prevalence and risk factors of ischemic stroke-related headache in China: a systematic review and meta-analysis[J]. BMC Public Health, 2022, 22(1): 1533. doi: 10.1186/s12889-022-13917-z
    [4]
    LOUHIJA U M, MARTOLA J, JUVA K, et al. Brain atrophy in first-episode psychosis of the elderly is associated with cognitive decline[J]. Prim Care Companion CNS Disord, 2021, 23(6): 20m02865.
    [5]
    BROUWER R M, KLEIN M, GRASBY K L, et al. Genetic variants associated with longitudinal changes in brain structure across the lifespan[J]. Nat Neurosci, 2022, 25(4): 421-432. doi: 10.1038/s41593-022-01042-4
    [6]
    H BUCK B, AKHTAR N, ALROHIMI A, et al. Stroke mimics: incidence, aetiology, clinical features and treatment[J]. Ann Med, 2021, 53(1): 420-436. doi: 10.1080/07853890.2021.1890205
    [7]
    ZHANG G, ZHU Y J, LING Y P, et al. Endovascular treatment of acute ischemic stroke due to isolated proximal posterior artery occlusion[J]. Front Surg, 2022, 9: 919509. doi: 10.3389/fsurg.2022.919509
    [8]
    中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组, 中华医学会神经病学分会神经血管介入协作组. 中国缺血性脑血管病血管内介入诊疗指南2015[J]. 中华神经科杂志, 2015, 48(10): 830-837. doi: 10.3760/cma.j.issn.1006-7876.2015.10.003
    [9]
    田元元. 阿司匹林联合阿托伐他汀钙治疗急性缺血性脑血管病的临床效果及安全性[J]. 临床合理用药杂志, 2020, 13(23): 52-53. https://www.cnki.com.cn/Article/CJFDTOTAL-PLHY202023023.htm
    [10]
    王勇. 血管内支架植入术治疗缺血性脑血管病的疗效及安全性研究[J]. 影像研究与医学应用, 2018, 2(23): 223-224. https://www.cnki.com.cn/Article/CJFDTOTAL-YXYY201823153.htm
    [11]
    潘鑫, 吴雪芹. 氯吡格雷联合血管内介入治疗对急性缺血性脑血管病的影响[J]. 中外医学研究, 2023, 9(11): 53-56. https://www.cnki.com.cn/Article/CJFDTOTAL-YJZY202311014.htm
    [12]
    KIM S W, LEE J K. Role of HMGB1 in the interplay between NETosis and thrombosis in ischemic stroke: a review[J]. Cells, 2020, 9(8): 1794. doi: 10.3390/cells9081794
    [13]
    孟迪, 吴云虎, 洪珂. 消栓肠溶胶囊联合脑蛋白水解物治疗缺血性脑血管病的临床疗效[J]. 临床合理用药杂志, 2022, 8(12): 55-57. https://www.cnki.com.cn/Article/CJFDTOTAL-PLHY202212017.htm
    [14]
    SUZUKI H, KANAMARU H, KAWAKITA F, et al. Cerebrovascular pathophysiology of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage[J]. Histol Histopathol, 2021, 36(2): 143-158.
    [15]
    LAI S W, LIAO K F, KUO Y H, et al. The risk of ischemic cerebrovascular disease associated with benzbromarone use in gout people: a retrospective cohort study in Taiwan[J]. Medicine, 2023, 102(5): e32779.
    [16]
    长春西汀注射液规范治疗专家组. 长春西汀注射液在缺血性脑血管病中的临床应用专家共识[J]. 中华老年心脑血管病杂志, 2020, 22(3): 243-248. https://www.cnki.com.cn/Article/CJFDTOTAL-LNXG202003008.htm
    [17]
    杨丽花, 丁凌, 徐敏. 血清Hcy、THBS-1、颈动脉超声血流参数预测缺血性脑卒中患者预后的价值[J]. 国际检验医学杂志, 2022, 8(21): 2591-2595. https://www.cnki.com.cn/Article/CJFDTOTAL-GWSQ202221008.htm
    [18]
    SHAIK A J, REDDY K, MOHAMMED N, et al. Neuron specific enolase as a marker of seizure related neuronal injury[J]. Neurochem Int, 2019, 131: 104509.
    [19]
    ANNESE T, RONCA R, TAMMA R, et al. PTX3 modulates neovascularization and immune inflammatory infiltrate in a murine model of fibrosarcoma[J]. Int J Mol Sci, 2019, 20(18): 4599.
    [20]
    LIU H, LI S C, XU Y Y, et al. Engeletin protects against cerebral ischemia/reperfusion injury by modulating the VEGF/vasohibin and Ang-1/Tie-2 pathways[J]. Rev Bras De Pesquisas Med E Biol, 2021, 54(10): e11028.
    [21]
    MOORE C L, HENRY D S, MCCLENAHAN S J, et al. Metoprolol impairs β1-adrenergic receptor-mediated vasodilation in rat cerebral arteries: implications for β-blocker therapy[J]. J Pharmacol Exp Ther, 2021, 376(1): 127-135.
    [22]
    王廉, 吕美萱, 许高权, 等. 缺血性脑血管病患者脑血管支架植入手术治疗的有效性及对患者并发症发生的影响[J]. 中国现代医生, 2021, 59(26): 78-81. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDYS202126023.htm
    [23]
    周晓闻, 庄建华, 刘洪超. 不同穿刺点止血方案对缺血性脑血管病患者脑血管内支架植入术后血管并发症的影响[J]. 血管与腔内血管外科杂志, 2021, 7(2): 183-187. https://www.cnki.com.cn/Article/CJFDTOTAL-XGQW202102014.htm
    [24]
    邢效如, 郝雅男, 孙志, 等. 血管内支架介入成形术对老年缺血性脑血管病患者的神经功能、动脉血流速度及预后的影响[J]. 现代生物医学进展, 2020, 20(12): 2289-2292, 2328. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202012018.htm
    [25]
    王楠. 血管内介入与药物治疗缺血性脑血管病的效果对比[J]. 中国卫生工程学, 2021, 20(5): 837-838. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWX202105053.htm
    [26]
    欧阳坤, 杨国栋, 唐英, 等. 颅内血管介入治疗老年缺血性脑血管病患者的疗效及对神经功能的影响[J]. 中国老年学杂志, 2022, 42(9): 2074-2076. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLXZ202209009.htm
  • Related Articles

    [1]FU Chenyang, ZHOU Ping, ZHANG Pin, HUI Li. Correlations of vaginal microecology with human papilloma virus and cervical lesion[J]. Journal of Clinical Medicine in Practice, 2023, 27(16): 37-42. DOI: 10.7619/jcmp.20221628
    [2]LEI Xiaoming, XUE Mengzhou, XIA Bin, LI Jing, GUO Pingping. Correlations of serum 25-hydroxyvitamin D and adiponectin with cognitive function in patients with white matter lesions[J]. Journal of Clinical Medicine in Practice, 2022, 26(19): 33-37. DOI: 10.7619/jcmp.20221686
    [3]ZHU Linsheng, CHANG Guizhi. Minimally invasive surgery in patients with space-occupying lesions of left hepatic lobe[J]. Journal of Clinical Medicine in Practice, 2020, 24(7): 69-71. DOI: 10.7619/jcmp.202007020
    [4]YANG Fubao, LIU Jiaojiao. Value of echocardiogram and electrocardiogram in diagnosis of Kawasaki disease patients with coronary artery lesions[J]. Journal of Clinical Medicine in Practice, 2020, 24(6): 47-50. DOI: 10.7619/jcmp.202006013
    [5]WANG Zefei, BAO Lei, TAN Hongwei. Effect of cervical loop electrosurgical excision procedure in treating high-grade squamous intraepithelial lesion and its impact on pregnancy outcomes[J]. Journal of Clinical Medicine in Practice, 2019, 23(21): 43-47. DOI: 10.7619/jcmp.201921013
    [6]WANG Chengxiu, ZHANG Liping. Effect of transvaginal excision of pregnancy lesion in cesarean scar and hysteroplasty in the treatment of cesarean scar pregnancy[J]. Journal of Clinical Medicine in Practice, 2019, 23(18): 84-86. DOI: 10.7619/jcmp.201918024
    [7]MA Yinghui, DAI Hao, LI Zhi, WANG Lingchun, MAO Jianying, LU Lingling, ZHAI Weitao. Relationship between rheumatoid arthritis flatfoot and flexor pollicis longus tendon lesion[J]. Journal of Clinical Medicine in Practice, 2017, (21): 68-70. DOI: 10.7619/jcmp.201721020
    [8]YANG Xiaoqin. Correlation between expressions of proliferating cell nuclear antigen, Ki-67 and HPV infection in cervical lesions[J]. Journal of Clinical Medicine in Practice, 2015, (17): 57-60. DOI: 10.7619/jcmp.201517018
    [9]WU Chucheng, PENG Weiqiang, HUANG Yukang, CHEN Shuru, FENG Decai. Application of Mammotome minimally invasive biopsy system in diagnosis and treatment of patietns with nonpalpable breast lesions[J]. Journal of Clinical Medicine in Practice, 2015, (3): 101-103. DOI: 10.7619/jcmp.201503030
    [10]LYU Jianxin, SHI Min, PAN Bo, WANG Xiaojun, DAI Luxian, YANG Xiaohong. Application of EnCor vacuum-assisted biopsy system in the diagnosis and treatment for breast lesions[J]. Journal of Clinical Medicine in Practice, 2014, (9): 108-111. DOI: 10.7619/jcmp.201409033
  • Cited by

    Periodical cited type(4)

    1. 李优明. 鲁拉西酮治疗精神分裂症的临床效果及安全性分析. 中国医学创新. 2024(21): 65-68 .
    2. 章华丽. 鲁拉西酮与帕利哌酮对精神分裂症患者认知功能及脂代谢水平的影响. 药品评价. 2024(06): 700-703 .
    3. 王争秒,石磊,耿文博. 鲁拉西酮联合哌罗匹隆治疗难治性精神分裂症的临床疗效. 深圳中西医结合杂志. 2024(20): 123-126 .
    4. 李雪芳. 精神分裂症治疗中鲁拉西酮的临床效果评估. 黑龙江中医药. 2024(05): 6-8 .

    Other cited types(0)

Catalog

    Article views PDF downloads Cited by(4)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return